| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.8 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.0091 | 0.9 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |